Skip to main content
Top
Published in: Lung 6/2010

01-12-2010

Pleuropericarditis in a Patient with Inflammatory Bowel Disease: A Case Presentation and Review of the Literature

Authors: Muhanned Abu-Hijleh, Samuel Evans, Bassam Aswad

Published in: Lung | Issue 6/2010

Login to get access

Abstract

Inflammatory bowel disease (IBD) can affect the lung parenchyma and airways. Rarely it involves the pleural space and pericardium, causing inflammatory exudative pleural and/or pericardial effusions. In this report, we describe a 76-year-old patient with recurrent sterile exudative pleuropericarditis that gradually responded to treatment with steroids, and we review the relevant literature. Thoracic serositis in patients with IBD can cause pleuritis, pericarditis, pleuropericarditis, or myopericarditis. This is a relatively rare presentation of the uncommon and probably underreported and underrecognized pulmonary extraintestinal manifestations of IBD. Pleuropericardial inflammatory disease and effusion can be directly related to IBD, its complications, associated infections, or the medications used to treat it. Serositis directly related to IBD is a diagnosis of exclusion. It is important to evaluate the pleural effusion and rule out other etiologies before making this diagnosis. Pleural or pericardial biopsies are rarely necessary, and probably show nonspecific acute and chronic inflammatory changes. Although the specific pathophysiology of pleuropericardial disease in patients with IBD remains unclear, the response to systemic steroids is usually adequate.
Literature
1.
go back to reference Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517CrossRefPubMed Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517CrossRefPubMed
2.
go back to reference Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA (2007) The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5(12):1424–1429CrossRefPubMed Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA (2007) The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5(12):1424–1429CrossRefPubMed
3.
go back to reference Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39(5):690–697CrossRefPubMed Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39(5):690–697CrossRefPubMed
4.
go back to reference Camus P, Piard F, Ashcroft T, Gal AA, Colby TV (1993) The lung in inflammatory bowel disease. Medicine (Baltimore) 72(3):151–183 Camus P, Piard F, Ashcroft T, Gal AA, Colby TV (1993) The lung in inflammatory bowel disease. Medicine (Baltimore) 72(3):151–183
5.
go back to reference Storch I, Sachar D, Katz S (2003) Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 9(2):104–115CrossRefPubMed Storch I, Sachar D, Katz S (2003) Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 9(2):104–115CrossRefPubMed
6.
go back to reference Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV (2003) Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol 27(2):213–219CrossRefPubMed Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV (2003) Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol 27(2):213–219CrossRefPubMed
7.
go back to reference Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A (2008) Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung 186(3):167–172CrossRefPubMed Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A (2008) Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung 186(3):167–172CrossRefPubMed
8.
go back to reference Kraft SC, Earle RH, Roesler M, Esterly JR (1976) Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 136(4):454–459CrossRefPubMed Kraft SC, Earle RH, Roesler M, Esterly JR (1976) Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 136(4):454–459CrossRefPubMed
9.
go back to reference Patwardhan RV, Heilpern RJ, Brewster AC, Darrah JJ (1983) Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature. Arch Intern Med 143(1):94–96CrossRefPubMed Patwardhan RV, Heilpern RJ, Brewster AC, Darrah JJ (1983) Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature. Arch Intern Med 143(1):94–96CrossRefPubMed
10.
go back to reference Rosenbaum AJ, Murphy PJ, Engel JJ (1983) Pleurisy during the course of ulcerative colitis. J Clin Gastroenterol 5(6):517–521CrossRefPubMed Rosenbaum AJ, Murphy PJ, Engel JJ (1983) Pleurisy during the course of ulcerative colitis. J Clin Gastroenterol 5(6):517–521CrossRefPubMed
11.
go back to reference Abid MA, Gitlin N (1990) Pericarditis—an extraintestinal complication of inflammatory bowel disease. West J Med 153(3):314–315PubMed Abid MA, Gitlin N (1990) Pericarditis—an extraintestinal complication of inflammatory bowel disease. West J Med 153(3):314–315PubMed
12.
go back to reference Bernstein CN, Wajda A, Blanchard JF (2005) The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129(3):827–836CrossRefPubMed Bernstein CN, Wajda A, Blanchard JF (2005) The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129(3):827–836CrossRefPubMed
13.
go back to reference Black H, Mendoza M, Murin S (2007) Thoracic manifestations of inflammatory bowel disease. Chest 131(2):524–532CrossRefPubMed Black H, Mendoza M, Murin S (2007) Thoracic manifestations of inflammatory bowel disease. Chest 131(2):524–532CrossRefPubMed
14.
go back to reference Ho GT, Innes JA, Shand AG, Satsangi J (2006) Bronchopulmonary manifestations of inflammatory bowel disease: a case report and literature review. J R Coll Phys Edin 36:299–303 Ho GT, Innes JA, Shand AG, Satsangi J (2006) Bronchopulmonary manifestations of inflammatory bowel disease: a case report and literature review. J R Coll Phys Edin 36:299–303
15.
go back to reference Wallaert B, Colombel JF, Tonnel AB, Bonniere P, Cortot A, Paris JC, Voisin C (1985) Evidence of lymphocyte alveolitis in Crohn’s disease. Chest 87(3):363–367CrossRefPubMed Wallaert B, Colombel JF, Tonnel AB, Bonniere P, Cortot A, Paris JC, Voisin C (1985) Evidence of lymphocyte alveolitis in Crohn’s disease. Chest 87(3):363–367CrossRefPubMed
16.
go back to reference Smiéjan JM, Cosnes J, Chollet-Martin S, Soler P, Basset FM, Le Quintrec Y, Hance AJ (1986) Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn’s disease. Ann Intern Med 104(1):17–21PubMed Smiéjan JM, Cosnes J, Chollet-Martin S, Soler P, Basset FM, Le Quintrec Y, Hance AJ (1986) Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn’s disease. Ann Intern Med 104(1):17–21PubMed
17.
go back to reference Adenis A, Colombel JF, Lecouffe P, Wallaert B, Hecquet B, Marchandise X, Cortot A (1992) Increased pulmonary and intestinal permeability in Crohn’s disease. Gut 33(5):678–682CrossRefPubMed Adenis A, Colombel JF, Lecouffe P, Wallaert B, Hecquet B, Marchandise X, Cortot A (1992) Increased pulmonary and intestinal permeability in Crohn’s disease. Gut 33(5):678–682CrossRefPubMed
18.
go back to reference Mohammed AR, Babu S (2008) Serositis and inflammatory bowel disease. Br J Hosp Med (Lond) 69(5):296–297 Mohammed AR, Babu S (2008) Serositis and inflammatory bowel disease. Br J Hosp Med (Lond) 69(5):296–297
19.
go back to reference Swinburn CR, Jackson GJ, Cobden I, Ashcroft T, Morritt GN, Corris PA (1988) Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 43(9):735–736CrossRefPubMed Swinburn CR, Jackson GJ, Cobden I, Ashcroft T, Morritt GN, Corris PA (1988) Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 43(9):735–736CrossRefPubMed
20.
go back to reference Faller M, Gasser B, Massard G, Pauli G, Quoix E (2000) Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn’s disease. Respiration 67(4):459–463CrossRefPubMed Faller M, Gasser B, Massard G, Pauli G, Quoix E (2000) Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn’s disease. Respiration 67(4):459–463CrossRefPubMed
21.
go back to reference Haralambou G, Teirstein AS, Gil J, Present DH (2001) Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med 68(6):384–388PubMed Haralambou G, Teirstein AS, Gil J, Present DH (2001) Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med 68(6):384–388PubMed
22.
go back to reference Parry SD, Barbatzas C, Peel ET, Barton JR (2002) Sulphasalazine and lung toxicity. Eur Respir J 19(4):756–764CrossRefPubMed Parry SD, Barbatzas C, Peel ET, Barton JR (2002) Sulphasalazine and lung toxicity. Eur Respir J 19(4):756–764CrossRefPubMed
23.
go back to reference Mukhopadhyay D, Nasr K, Grossman BJ, Kirsner JB (1970) Pericarditis associated with inflammatory bowel disease. JAMA 211(9):1540–1542CrossRefPubMed Mukhopadhyay D, Nasr K, Grossman BJ, Kirsner JB (1970) Pericarditis associated with inflammatory bowel disease. JAMA 211(9):1540–1542CrossRefPubMed
24.
go back to reference Breitenstein RA, Salel AF, Watson DW (1974) Chronic inflammatory bowel disease: acute pericarditis and pericardial tamponade [letter]. Ann Intern Med 81(3):406PubMed Breitenstein RA, Salel AF, Watson DW (1974) Chronic inflammatory bowel disease: acute pericarditis and pericardial tamponade [letter]. Ann Intern Med 81(3):406PubMed
25.
go back to reference Thompson DG, Lennard-Jones JE, Swarbrick ET, Bown R (1979) Pericarditis and inflammatory bowel disease. Q J Med 48(189):93–97PubMed Thompson DG, Lennard-Jones JE, Swarbrick ET, Bown R (1979) Pericarditis and inflammatory bowel disease. Q J Med 48(189):93–97PubMed
26.
go back to reference Puntis JW, Tarlow MJ, Raafat F, Booth IW (1990) Crohn’s disease of the lung. Arch Dis Child 65(11):1270–1271CrossRefPubMed Puntis JW, Tarlow MJ, Raafat F, Booth IW (1990) Crohn’s disease of the lung. Arch Dis Child 65(11):1270–1271CrossRefPubMed
27.
go back to reference Orii S, Chiba T, Nakadate I, Fujiwara T, Ito N, Ishii M, Oana S, Chida T, Kudara N, Terui T, Yamaguchi T, Suzuki K (2001) Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis. J Clin Gastroenterol 32(3):251–254CrossRefPubMed Orii S, Chiba T, Nakadate I, Fujiwara T, Ito N, Ishii M, Oana S, Chida T, Kudara N, Terui T, Yamaguchi T, Suzuki K (2001) Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis. J Clin Gastroenterol 32(3):251–254CrossRefPubMed
28.
go back to reference Stajer D, Gorjup V (1996) Myopericarditis, pleuritis and deep venous thrombosis in ulcerative colitis masquerading as pulmonary embolism. Intensive Care Med 22(10):1134–1135CrossRefPubMed Stajer D, Gorjup V (1996) Myopericarditis, pleuritis and deep venous thrombosis in ulcerative colitis masquerading as pulmonary embolism. Intensive Care Med 22(10):1134–1135CrossRefPubMed
Metadata
Title
Pleuropericarditis in a Patient with Inflammatory Bowel Disease: A Case Presentation and Review of the Literature
Authors
Muhanned Abu-Hijleh
Samuel Evans
Bassam Aswad
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Lung / Issue 6/2010
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9259-y

Other articles of this Issue 6/2010

Lung 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.